Prostate cancer decisions — 2025

The Board granted service connection for prostate cancer, finding a causal relationship between the Veteran's in-service asbestos exposure and his current condition.

The Board dismissed the appeals for increased ratings due to non-compliance with claims processing rules, but granted TDIU based on the Veteran's service-connected disabilities.

The Board granted service connection for prostate cancer and ischemic heart disease (IHD) based on presumptive exposure to herbicide agents during the Veteran's active service at Don Muang Royal Thai Air Force Base and Udorn RTAFB.

The Board granted service connection for type II diabetes, prostate cancer, and bladder cancer urothelial carcinoma based on the Veteran's exposure to contaminated water at Camp Lejeune.

The Board remands the claim for service connection for prostate cancer to correct a duty to assist error, specifically requiring an updated opinion on whether the Veteran's service-connected epididymitis caused or aggravated his prostate cancer.

The Board remands the matters for the AOJ to correct pre-decisional errors in its efforts to assist the appellant with the development of his claims, specifically regarding outstanding relevant private treatment records.

The Board denied service connection for prostate cancer and diabetes mellitus, as well as the cause of death, finding no credible evidence linking these conditions to the Veteran's active military service.

The Board denied an initial rating in excess of 20 percent for stress incontinence male residual of prostatectomy, history of malignant neoplasm prostate cancer, but granted service connection for erectile dysfunction as secondary to the Veteran's service-connected conditions.

The appeals for service connection for posttraumatic stress disorder (PTSD), left kidney cancer and residuals, and prostate cancer and residuals are dismissed as there remains no question of law or fact for the Board to resolve.

The appeal for a disability rating in excess of 30 percent for posttraumatic stress disorder was dismissed, and the effective dates for service connection for diabetes mellitus, type II, and related peripheral neuropathies were denied.

The Board granted readjudication of the claims for service connection for prostate cancer, stage IV and emphysema based on new evidence but remanded other issues for further development.

The Board granted service connection for prostate cancer and coronary artery disease, both presumed to be due to in-service exposure to herbicides. The claims for hypertension, erectile dysfunction, and peripheral vascular disease were remanded.

The Board remands the service connection claims for prostate cancer, hypertension, and bilateral knee disorders due to pre-decisional duty to assist errors.

The Board remands the claims for service connection for prostate cancer, Parkinson's disease, and basal cell carcinoma on the basis of substitution due to a need for additional development.

The Board denied service connection for hypertension, coronary artery disease, congestive heart failure, carotid artery disease blockage with surgery, peripheral arterial disease, prostate cancer, bladder cancer, kidney cancer, and anxiety and depression as not being related to the Veteran's active duty or any herbicide exposure.

The Board granted an earlier effective date of February 5, 2024, for the award of service connection for prostate cancer.

The Board remands the claims for service connection for various conditions due to a need for VA examinations to explore their etiologies, particularly in relation to potential toxic exposures during service.

The Board remands the claim for an adequate medical opinion regarding whether the Veteran's prostate cancer is related to his military service, specifically addressing exposures at Camp Lejeune.

The Board granted an effective date of January 27, 2012 for the award of Dependency and Indemnity Compensation (DIC) based on direct service connection for the Veteran's cause of death and eligibility for Dependency Education Assistance (DEA) under 38 U.S.C. Chapter 35.

The Board remands the claims for service connection for prostate cancer and thyroid condition due to inadequate VA examinations.